SCHEMBL31340370

SCHEMBL31340370

CCOC(=O)[C@H]1CCN(C(=O)OCc2ccccc2)C[C@@H]1NC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
CYP2C19 P33261 1/20 0.47
HTT P42858 1/20 0.46
CPB1 P15086 1/20 0.45
GPR119 Q8TDV5 1/20 0.43
CTSL P07711 1/20 0.42
SYK P43405 1/20 0.42
MAPT P10636 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSD11B1 P28845 1/20 0.42
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6347796 0.93 CPB1 (0.49) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL16164661 0.87 PDE4B (0.56) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL14911483 0.87 PDE4B (0.56) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL16096196 0.87 PDE4B (0.57) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL13707624 0.86 PDE4B (0.56) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL16841203 0.86 PDE4B (0.56) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL18258160 0.86 PDE4B (0.53) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL18247458 0.86 PDE4B (0.53) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL21335664 0.86 PDE4B (0.53) PDE4BSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL376543 0.86 PDE4B (0.53) PDE4BSMN1; SMN2NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747250-A1 KINASE INHIBITORS The United States Of America, As Represented By The Secretary, Department of Health and Human Services (US) 2026-05-27 EP disclosed
WO-2025019585-A1 KINASE INHIBITORS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2025-01-23 WO disclosed